|
Dec 14
|
These Stocks Are Moving the Most Today: Moderna, Rivian, SolarEdge, Adobe, Opendoor, Illumina, Foot Locker, and More
|
|
Dec 14
|
Moderna: Stock soars on cancer vaccine data, CEO Bancel takes on commercial role
|
|
Dec 14
|
These Stocks Are Moving the Most Today
|
|
Dec 14
|
Moderna Stock Surges After Positive Trial Results
|
|
Dec 14
|
Company News for Dec 14, 2023
|
|
Dec 14
|
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?
|
|
Dec 14
|
Pfizer (PFE) Stock Sinks on Weak 2024 View as COVID Sales Fall
|
|
Dec 14
|
Pfizer Completes Acquisition of Seagen
|
|
Dec 14
|
Markets Rejoice as Fed Doves Take Flight. Why Stocks Are Soaring.
|
|
Dec 14
|
Trending tickers: Apple | Adobe | Pfizer | Currys
|
|
Dec 10
|
12 Healthcare Stocks Billionaires Like the Most
|
|
Dec 10
|
Pfizer marks progress for successor sickle cell drug at ASH
|
|
Dec 10
|
Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B
|
|
Dec 9
|
ASH23: CAR-T for autoimmune disease, real-world questions and sickle cell’s social media mentions
|
|
Dec 9
|
3 Dividend Stocks Trading at 52-Week Lows
|
|
Dec 9
|
Is Pfizer (NYSE:PFE) Using Too Much Debt?
|
|
Dec 8
|
Pfizer's Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy?
|
|
Dec 8
|
10 Cheap Dividend Stocks with High Yields
|
|
Dec 8
|
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
|
|
Dec 8
|
European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma
|